$VGZ
VISTA GOLD CORP

2024 Q2 Form 10-Q Financial Statement

#000078332424000048 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue -$16.91M
YoY Change
Gross Profit $16.91M
YoY Change
Gross Profit Margin
Selling, General & Admin $763.0K $1.243M
YoY Change -13.1% 6.42%
% of Gross Profit 4.51%
Research & Development $645.0K $765.0K
YoY Change -5.43% -4.85%
% of Gross Profit 3.81%
Depreciation & Amortization $14.00K $12.00K
YoY Change 40.0% 20.0%
% of Gross Profit 0.08%
Operating Expenses -$15.49M $1.218M
YoY Change -1086.43% -38.55%
Operating Profit $32.40M
YoY Change
Interest Expense $163.0K $103.0K
YoY Change 132.86% 49.28%
% of Operating Profit 0.5%
Other Income/Expense, Net $146.0K $145.0K
YoY Change 117.91% 1218.18%
Pretax Income $15.63M -$1.073M
YoY Change -1140.12% -45.56%
Income Tax
% Of Pretax Income
Net Earnings $15.63M -$1.073M
YoY Change -1140.12% -45.56%
Net Earnings / Revenue
Basic Earnings Per Share $0.13 -$0.01
Diluted Earnings Per Share $0.12 -$0.01
COMMON SHARES
Basic Shares Outstanding 121.8M 121.5M
Diluted Shares Outstanding 125.4M 121.2M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.23M $11.91M
YoY Change 237.87% 79.28%
Cash & Equivalents $20.23M $11.91M
Short-Term Investments
Other Short-Term Assets $334.0K $455.0K
YoY Change -2.34% 2.02%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.56M $12.37M
YoY Change 224.89% 74.42%
LONG-TERM ASSETS
Property, Plant & Equipment $260.0K $243.0K
YoY Change 50.29% 32.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $69.00K $69.00K
YoY Change
Total Long-Term Assets $412.0K $2.962M
YoY Change -82.23% 27.18%
TOTAL ASSETS
Total Short-Term Assets $20.56M $12.37M
Total Long-Term Assets $412.0K $2.962M
Total Assets $20.97M $15.33M
YoY Change 142.52% 62.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $190.0K $354.0K
YoY Change 245.45% 62.39%
Accrued Expenses $613.0K $814.0K
YoY Change -12.8% 31.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $803.0K $1.168M
YoY Change 5.94% 39.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $28.00K $25.00K
YoY Change -22.22% -24.24%
Total Long-Term Liabilities $28.00K $10.03M
YoY Change -22.22% 30278.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $803.0K $1.168M
Total Long-Term Liabilities $28.00K $10.03M
Total Liabilities $831.0K $11.19M
YoY Change 4.66% 1183.6%
SHAREHOLDERS EQUITY
Retained Earnings -$456.8M -$472.5M
YoY Change -2.44% 1.22%
Common Stock $477.0M $476.6M
YoY Change 0.18% 0.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.14M $4.137M
YoY Change
Total Liabilities & Shareholders Equity $20.97M $15.33M
YoY Change 142.52% 62.74%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $15.63M -$1.073M
YoY Change -1140.12% -45.56%
Depreciation, Depletion And Amortization $14.00K $12.00K
YoY Change 40.0% 20.0%
Cash From Operating Activities -$1.377M -$1.416M
YoY Change 12.96% -20.27%
INVESTING ACTIVITIES
Capital Expenditures $31.00K $51.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $9.476M $7.396M
YoY Change
Cash From Investing Activities $9.445M $7.345M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 244.0K -85.00K
YoY Change -56.43% -127.33%
NET CHANGE
Cash From Operating Activities -1.377M -1.416M
Cash From Investing Activities 9.445M 7.345M
Cash From Financing Activities 244.0K -85.00K
Net Change In Cash 8.312M 5.844M
YoY Change -1361.31% -498.91%
FREE CASH FLOW
Cash From Operating Activities -$1.377M -$1.416M
Capital Expenditures $31.00K $51.00K
Free Cash Flow -$1.408M -$1.467M
YoY Change 15.5% -17.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000783324
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2023 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-09025
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
VISTA GOLD CORP.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0542444
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8310 S Valley Hwy, Suite 300
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Englewood
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
CY2024Q1 dei City Area Code
CityAreaCode
720
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
981-1185
CY2024Q1 dei Security12b Title
Security12bTitle
Common Shares, no par value
CY2024Q1 dei Trading Symbol
TradingSymbol
VGZ
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
121754045
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11913000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6069000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
455000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
446000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
12368000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6515000
CY2024Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
2650000
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
2146000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
243000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
204000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
69000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
69000
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
2962000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2419000
CY2024Q1 us-gaap Assets
Assets
15330000
CY2023Q4 us-gaap Assets
Assets
8934000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
354000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
190000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
814000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
749000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1168000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
939000
CY2024Q1 us-gaap Deferred Gain On Sale Of Property
DeferredGainOnSaleOfProperty
10000000
CY2023Q4 us-gaap Deferred Gain On Sale Of Property
DeferredGainOnSaleOfProperty
3000000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
25000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
44000
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10025000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3044000
CY2024Q1 us-gaap Liabilities
Liabilities
11193000
CY2023Q4 us-gaap Liabilities
Liabilities
3983000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121634045
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121088494
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
476613000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
476354000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-472476000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-471403000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4137000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4951000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15330000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8934000
CY2024Q1 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
765000
CY2023Q1 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
804000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1243000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1168000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10000
CY2024Q1 vgz Gain Loss On Disposition Of Assets Net
GainLossOnDispositionOfAssetsNet
802000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1218000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1982000
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
103000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
69000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
42000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-58000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
145000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1073000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1971000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1073000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1971000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121217992
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119041318
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121217992
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119041318
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10029000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
453000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-142000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
179000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1971000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8548000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4951000
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
53000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-85000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
291000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1073000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4137000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-1073000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1971000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
291000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
179000
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
900000
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-44000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-91000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
210000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-85000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1416000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1776000
CY2024Q1 vgz Proceeds From Grant Of Royalty Interests In Mining Properties
ProceedsFromGrantOfRoyaltyInterestsInMiningProperties
7000000
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
900000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
51000
CY2024Q1 vgz Payments To Develop Mineral Reserves
PaymentsToDevelopMineralReserves
504000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7345000
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
453000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
85000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
142000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-85000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
311000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5844000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1465000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6069000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8110000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11913000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6645000
CY2024Q1 vgz Payments To Develop Mineral Reserves
PaymentsToDevelopMineralReserves
504000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5769000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5526000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
243000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5718000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5514000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
204000
CY2024Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
310000
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
152000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
504000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
597000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
814000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
749000
CY2024Q1 vgz Percentage Of Issued And Outstanding Common Shares For Stock Based Compensation Plan
PercentageOfIssuedAndOutstandingCommonSharesForStockBasedCompensationPlan
0.10
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
291000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1367000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y7M20D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
967000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.71
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
400000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.70
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y5M19D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
400000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.70
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y3M
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
400000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.70
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y3M
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3000
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000783324-24-000048-index-headers.html Edgar Link pending
0000783324-24-000048-index.html Edgar Link pending
0000783324-24-000048.txt Edgar Link pending
0000783324-24-000048-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vgz-20240331.xsd Edgar Link pending
vgz-20240331x10q.htm Edgar Link pending
vgz-20240331x10q001.jpg Edgar Link pending
vgz-20240331xex23d1.htm Edgar Link pending
vgz-20240331xex23d2.htm Edgar Link pending
vgz-20240331xex23d3.htm Edgar Link pending
vgz-20240331xex23d4.htm Edgar Link pending
vgz-20240331xex31d1.htm Edgar Link pending
vgz-20240331xex31d2.htm Edgar Link pending
vgz-20240331xex32d1.htm Edgar Link pending
vgz-20240331xex32d2.htm Edgar Link pending
vgz-20240331_def.xml Edgar Link unprocessable
vgz-20240331_lab.xml Edgar Link unprocessable
vgz-20240331_pre.xml Edgar Link unprocessable
vgz-20240331x10q_htm.xml Edgar Link completed
vgz-20240331_cal.xml Edgar Link unprocessable